By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Hemispherx Biopharma Inc. 

One Penn Center
1617 JFK Boulevard
Philadelphia  Pennsylvania  19103  U.S.A.
Phone: 215-988-0080 Fax: 215-988-1739


SEARCH JOBS








Company News
Hemispherx (HEB) Announces Corporate Progress And Financial Results For The Six Months Ended June 30, 2017 8/15/2017 10:15:46 AM
Hemispherx (HEB) Announces Corporate Progress And Financial Results For The Six Months Ended June 30, 2017 8/15/2017 7:04:42 AM
Hemispherx (HEB) Human Safety Study Of Intranasal Ampligen With Influenza Vaccine Shows Ampligen Was Generally Well-Tolerated 8/14/2017 8:52:40 AM
Hemispherx (HEB) To Host Conference Call To Discuss Second Quarter Financial Results On Tuesday, August 15, 2017 8/14/2017 8:38:04 AM
Hemispherx (HEB) Human Safety Study Of Intranasal Ampligen With Influenza Vaccine Shows Ampligen Was Generally Well-Tolerated 8/14/2017 7:58:33 AM
Hemispherx (HEB) Updates Status of Immuno-Oncology Program in Pancreatic Cancer 7/10/2017 2:18:33 PM
Hemispherx (HEB) Enhances Ampligen Manufacturing And Scientific Capabilities 6/1/2017 1:51:23 PM
Hemispherx (HEB) Repurposes Ampligen In Immuno-Oncology 6/1/2017 8:17:55 AM
Hemispherx (HEB) Announces Financial Results For The Three Months Ended March 31, 2017 5/16/2017 11:08:19 AM
Hemispherx (HEB) Announces Financial Results For The Year Ended December 31, 2016 4/3/2017 2:07:42 PM
12345678910...
//-->